These effects, along with a prior report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the idea of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Conditions. In response to this https://marceller848wcf6.ourabilitywiki.com/user